Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study

Chimeric antigen receptor T-cell therapy (CAR-T) has been successful in treating relapsed/refractory B-cell lymphomas. However, its role in the treatment of diseases involving the central nervous system (CNS) is not well studied. We performed a multicenter retrospective cohort study to evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Epperla, Narendranath, Feng, Lei, Shah, Nirav N., Fitzgerald, Lindsey, Shah, Harsh, Stephens, Deborah M., Lee, Catherine J., Ollila, Thomas, Shouse, Geoffrey, Danilov, Alexey V., David, Kevin A., Torka, Pallawi, Hashmi, Hamza, Hess, Brian, Barta, Stefan K., Romancik, Jason T., Cohen, Jonathon B., Annunzio, Kaitlin, Kittai, Adam S., Reneau, John, Zurko, Joanna, Nizamuddin, Imran A., Winter, Jane N., Gordon, Leo I., Ma, Shuo, Patel, Romil, Nastoupil, Loretta, Ahmed, Sairah, Karmali, Reem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10633964/
https://www.ncbi.nlm.nih.gov/pubmed/37946255
http://dx.doi.org/10.1186/s13045-023-01508-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10633964/
https://www.ncbi.nlm.nih.gov/pubmed/37946255
http://dx.doi.org/10.1186/s13045-023-01508-3

Ejemplares similares